Tesla stock fell 1.3 percent to $398.50 in premarket trading, weighed by persistent concerns over softening electric vehicle demand in key global markets. Investors are waiting for preliminary Q4 delivery numbers—expected to show deceleration from prior quarters—and clarity on margin sustainability during price competition. Tesla's Jan. 24 earnings call will be the next major catalyst.
Trump Media & Technology Group shares remained volatile in early trading. The stock exhibits sharp daily swings driven by political news and retail investor engagement, compounded by elevated short interest. The approaching expiration of its lock-up period—which will release a large block of shares—poses a material risk to current valuations and could force institutional holders to reassess positions.
CorWeave, a private cloud provider for AI infrastructure, drew premarket attention as AI chip demand accelerates. Nvidia, a CoreWeave investor and partner, rose 2.3 percent to $206.69. CoreWeave's expanding data center footprint and recent funding rounds signal sustained capital deployment into specialized AI computing resources.
Novo Nordisk faced investor scrutiny over long-term GLP-1 drug economics. Demand for Ozempic and Wegovy continues to far exceed manufacturing capacity globally, but rival pharmaceuticals are advancing similar treatments through trials. Pricing power, market size expansion, and pipeline depth will determine whether Novo maintains its market leadership.
The S&P 500 rose 0.4 percent to $7,569 and the Nasdaq gained 0.8 percent to $25,372, reflecting a market focused on company-specific catalysts and sector dynamics. The Nov. 14 consumer price index report will be a key market inflection point.
